Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms.
body mass index
diabetes mellitus
long-term functional outcomes
neuroendocrine tumor
pancreatectomy
pancreatic exocrine insufficiency
pancreatic neuroendocrine neoplasms
parenchyma-sparing surgery
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
03 Oct 2019
03 Oct 2019
Historique:
received:
30
08
2019
revised:
23
09
2019
accepted:
27
09
2019
entrez:
19
10
2019
pubmed:
19
10
2019
medline:
19
10
2019
Statut:
epublish
Résumé
Radical surgery represents the only curative treatment for pancreatic neuroendocrine neoplasms (PanNEN). The aim of this study was to evaluate the postoperative onset of diabetes mellitus (DM) and/or pancreatic exocrine insufficiency (PEI) in surgically treated PanNEN. Consecutive PanNEN patients, without preoperative DM, who underwent partial pancreatic resection, were included. After a median follow-up of 72 months, overall 68/276 patients (24%) developed DM. Patients who developed DM were significantly older (
Identifiants
pubmed: 31623399
pii: jcm8101611
doi: 10.3390/jcm8101611
pmc: PMC6832294
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
HPB (Oxford). 2016 Apr;18(4):360-6
pubmed: 27037206
J Clin Endocrinol Metab. 2013 Dec;98(12):4784-9
pubmed: 24057286
Neuroendocrinology. 2016;103(2):153-71
pubmed: 26742109
Surgery. 2017 Mar;161(3):584-591
pubmed: 28040257
Dig Dis Sci. 2003 Mar;48(3):533-8
pubmed: 12757166
Int J Surg. 2016 Apr;28 Suppl 1:S172-6
pubmed: 26708862
ANZ J Surg. 2012 Jun;82(6):447-51
pubmed: 22571457
J Gastrointest Surg. 2014 Sep;18(9):1597-603
pubmed: 25002020
JAMA Oncol. 2017 Oct 1;3(10):1335-1342
pubmed: 28448665
Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4310-4318
pubmed: 30024621
J Gastrointest Surg. 2012 Dec;16(12):2212-9
pubmed: 23054900
Surgery. 2014 Feb;155(2):271-9
pubmed: 24287147
Pancreatology. 2009;9(6):729-37
pubmed: 20090394
Br J Surg. 2008 Jan;95(1):85-91
pubmed: 18041022
Br J Surg. 2007 Oct;94(10):1254-9
pubmed: 17583892
J Gastrointest Surg. 2012 Jul;16(7):1347-53
pubmed: 22528577
Surgery. 2011 Jul;150(1):75-82
pubmed: 21683859
Pancreatology. 2019 Jun;19(4):595-601
pubmed: 31005377
Ann Surg. 2018 Jun;267(6):1148-1154
pubmed: 28594340
Best Pract Res Clin Endocrinol Metab. 2019 Oct;33(5):101294
pubmed: 31351817
Gastroenterology. 2000 Nov;119(5):1324-32
pubmed: 11054391
Clin Exp Gastroenterol. 2019 Mar 21;12:129-139
pubmed: 30962702
World J Surg. 2015 Jun;39(6):1557-66
pubmed: 25691214
J Korean Med Sci. 2010 Jan;25(1):97-103
pubmed: 20052354
Pancreas. 2015 Nov;44(8):1296-303
pubmed: 26390413
Pancreatology. 2013 Jan-Feb;13(1):38-42
pubmed: 23395568
Surgery. 2009 Feb;145(2):168-75
pubmed: 19167971
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Obes Surg. 2011 Mar;21(3):351-5
pubmed: 21128002
Am J Transplant. 2016 Jun;16(6):1812-26
pubmed: 26695701
Virchows Arch. 2007 Oct;451(4):757-62
pubmed: 17674042
Eur J Surg Oncol. 2019 May;45(5):788-792
pubmed: 30527222
Pancreatology. 2011;11(6):535-45
pubmed: 22094930
Pancreatology. 2015 Sep-Oct;15(5):449-455
pubmed: 26145836
Am Surg. 2014 Jul;80(7):704-9
pubmed: 24987904
J Gastrointest Surg. 2006 Nov;10(9):1225-9
pubmed: 17114009
Ann Surg Oncol. 2010 Jun;17(6):1621-7
pubmed: 20162460
Arch Surg. 2002 Feb;137(2):164-8
pubmed: 11822953
Diabetes Care. 2019 Jan;42(Suppl 1):S13-S28
pubmed: 30559228
Br J Surg. 2013 Jun;100(7):873-85
pubmed: 23640664
Pancreatology. 2007;7(1):37-44
pubmed: 17449964
Expert Rev Gastroenterol Hepatol. 2018 Jul;12(7):723-731
pubmed: 29923433
Am J Surg. 2009 Sep;198(3):e49-53
pubmed: 19716880
J Gastrointest Surg. 2019 Aug;23(8):1604-1613
pubmed: 30671791
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Ann Surg Oncol. 2013 Sep;20(9):2815-21
pubmed: 23771245
Eur J Surg Oncol. 2018 Jun;44(6):778-783
pubmed: 29610023
J Gastrointest Surg. 2008 Sep;12(9):1548-53
pubmed: 18543045
Ann Endocrinol (Paris). 2018 Apr;79(2):53-61
pubmed: 29526248